ArticleApoptosis : an international journal on programmed cell death2025

Lenvatinib inhibits cholangiocarcinoma progression by targeting the FGF19/PI3K/AKT signaling pathway.

Yingcheng Wei et al.PubMed ↗Publisher ↗

No numbers read from the abstract.